摘要
观察古拉定治疗酒精性肝病的疗效。60例酒精性肝病患者随机分为A组(治疗组)和B组(对照组),分别用古拉定和门冬氨酸钾镁治疗,疗程均为4周。治疗组总有效率96.7％,与对照组相比差异显著(P<0.01),治疗组显效所需时间平均为9.8±6.5天,明显少于对照组(P<0.01),治疗组ALT、AST、γ-GT复常分别为96.7％、93.3％、90％,与对照组相比差异显著(P<0.01),治疗组ALT AST、γ-GT,下降幅度均明显高于对照组(P<0.01)。古拉定治疗酒精性肝病疗效较好,优于门冬氨酸钾镁。
To observe the efficacy of Gluthion on the treament of alcoholic liver diseases. In this series, 60 patients with alcoholic liver diseases were randomly divided into group A and group B. Patients in Group A received Gluthion for four weeks, patitents in Group B received potassium magnesium aspartate for four weeks. In Group A, at the end of treament, the total efiiective rate was 96.7% , which was significantly higher than that in Group B (P < 0.01). Time of marked efiiective was 9.8 ± 6.5 day, which was significantly shorter than that in Group B ( P < 0.01). The decrease of ALT AST and γ - GT after treatment were more significant in Group A than that in Group B (P<0.01). The recovery rate of ALT AST and γ-GT were 96.7%、93.3%、90% , respectively in Group A, which were significantly higher than that in Group B ( P < 0.01). Gluthion has better efficacy than potassium magnesium aspartate on the treatment of patients with alcoholic liver diseases. Patients with alcoholic liver diseases should be advised to receive Gluthion.
出处
《临床肝胆病杂志》
CAS
北大核心
2003年第1期40-41,共2页
Journal of Clinical Hepatology
